J L Kelly1, C B O'Suilleabhain, C C Soberg
1Department of Surgery (Immunology), Harvard Medical School/Brigham and Women's Hospital, Boston, MA 02115, USA.
Severe injury impairs T-helper-1 (Th1) cell function, reducing antibody and cytokine production. Interleukin-12 (IL-12) therapy can restore Th1 function in injured hosts.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: